Integrated Clinical-Molecular Classification of Colorectal Liver Metastases
1. The immune subtype demonstrated an improved progression-free survival (HR 0.37) and overall survival (HR 0.56) compared with the canonical ...
Tag: advanced colorectal cancer
Induction Therapy for Patients with Metastatic Colorectal Cancer and Liver Metastases
1. In patients with right-sided or RAS/BRAFV600E mutated tumors, the PFS was favorable with FOLFOXIRI plus bevacizumab compared to FOLFOX ...
Trifluridine–Tipiracil and Bevacizumab Improves Survival in Metastatic Pretreated Colorectal Cancer
1. The median overall survival was 10.8 months in the combination group (FTD–TPI + bevacizumab) and 7.5 months in the ...
Adagrasib provides antitumour activity against KRAS G12C mutant metastatic colorectal cancer both as monotherapy and in combination with cetuximab
1. Overall tumour response to monotherapy treatment with adagrasib was 23% 46% in combination with cetuximab. 2. Median progression-free survival ...